Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,468 total articles
United Parcel Service (UPS) has pulled the plug on low-margin Amazon volume, cut complexity from its U.S. network, and is seeing early signs of international recovery. At today's price near $102, UPS offers a 6%+ yield, $5.5B in free cash flow, and a PE of ~19. The trade: buy for mid-term upside to $120 with a $95 stop, sized for a medium-risk allo…
Unusual Machines (UMAC) looks priced for perfection. A weak Q3 will likely compress the stock near-term, but that same weakness could create an attractive entry into a company with clear sector catalysts: Pentagon interest, Russell 2000 inclusion tailwinds, and partner activity in the $1B Drone Dominance program. We outline an actionable long trade…
Root's telematics-first model has crossed the inflection point: the company is profitable, posting strong cash flow while maintaining underwriting discipline. At a market cap near $830M and free cash flow of $194.5M, the stock looks materially undervalued versus its recent performance and optionality from embedded partnerships. This trade idea outl…
Carlyle trades near $41 with an attractive income kicker and multiple fee-growth levers (wealth push, credit, and strategic buyouts). The shares are oversold technically (RSI ~27) and trade at a reasonable EV/EBITDA (10.2) vs. private-market optionality. I favor a tactical long for patient investors—entry $40.50, target $55.00, stop $37.50—over a 1…
Microsoft's pullback has created a controlled entry for traders. Fundamental cash generation, diversified revenue streams and still-firm fundamentals argue for a mid-term long. This trade plan targets a rebound toward $540 with a defined stop at $480 over a 45-trading-day horizon.
e.l.f. Beauty is trading at a premium, but recent operational wins - a $160M Rhode contribution in Q1, raised FY27 guidance (18-20% top-line) and a $58.5M tariff refund tailwind - argue for upside. We outline a mid-term trade that leans on continued Rhode distribution expansion, haircare momentum and margin recovery while protecting capital against…
Five9 has the software stack large enterprises need to automate customer interactions. Financials show positive free cash flow ($209M) and a reasonable EV relative to sales ($2.93B EV, EV/Sales ~2.44). With recent validation on enterprise AI uptake and an attractive mid-term technical setup, I outline a swing-long trade for the coming 45 trading da…
Backblaze is translating AI demand into concrete revenue wins — most notably a large $335M CoreWeave storage pact and double-digit topline growth — but aggressive pricing and upfront investment for AI customers will pressure margins near term. This trade seeks to capture continued top-line re-rating while controlling downside risk with a defined st…
Vulcan Materials (VMC) is trading near its 52-week low despite solid cash flow, modest leverage, and an incremental catalyst set from infrastructure spending and potential pricing leverage. At an EV/EBITDA of 15.5x and free cash flow of $1.03B, the stock offers a high-reward, high-risk opportunity: if aggregates demand and pricing recover and Vulca…
Sanmina is benefiting from a structural shift in demand for AI server racks and associated subsystems. With FCF near $594M, improving margins, and a market cap of roughly $10.4B, the stock offers a compelling risk-reward for a long trade over the next 180 trading days. This idea lays out entry at $194.39, stop at $170.00 and a target of $260.00, pl…
AppLovin (APP) has been punished hard — a 43.65% drawdown from peak — but the business still produces strong free cash flow, exceptional margins, and attractive ROE. This trade idea lays out a long-term (180 trading days) buy with exact entry, stop and target, and a balanced risk framework.
Tetra Technologies (TTI) sits at the intersection of two secular trends that matter to oilfield services and specialty chemicals: growing demand for engineered completion fluids and an expanding market for water management and desalination solutions. With a ~$962M market cap, positive revenue momentum, and an EV/EBITDA of 11.16, TTI looks like an a…
MakeMyTrip (MMYT) looks like a tactical long after recent weakness: the shares trade below near-term technicals and are materially oversold (RSI ~30), while corporate wins, an OpenAI tie-up and a planned local listing could re-rate the stock. Valuation is rich on headline multiples, but a successful India listing and continued margin recovery provi…
VVX has pulled back into the low $70s on heavy shorting and a momentum washout. The fundamentals - a multi-billion dollar contract backlog, positive adjusted earnings growth, and $121.5M in free cash flow - support a tactical long. We'll outline an entry at $72.09, stop at $66.00, and a target at $85.00 for a mid-term trade (45 trading days).
Salesforce's Agentforce adoption and record buyback program have materially de-risked the story. With stabilized double-digit revenue growth, free cash flow strength and a valuation that doesn't fully price sustained AI-driven monetization, we lay out a long-term trade plan: entry $258.72, target $320.00, stop $235.00, horizon 180 trading days.
On Holding (ONON) plunged after its latest quarter on a modest revenue miss and analyst downgrades, but its underlying margins, direct-to-consumer momentum, and APAC strength argue the pullback is disconnected from fundamentals. The technical set-up and heavy short activity create a tactical swing opportunity. Trade plan provided with precise entry…
Amplitude has moved back above key moving averages on accelerating volume, supported by renewed free cash flow, product momentum in AI analytics and a sizeable buyback authorization. With a $1.7B market cap and a compressed risk premium after months of weakness, we favor a tactical long into this rebound while guarding downside with a tight stop.
Dorchester Minerals (DMLP) looks like a classic royalty/mineral income story: high cash conversion, meaningful free cash flow, and a portfolio that grows through accretive acreage deals. Expect a distribution compression next quarter; that will be noisy and likely trigger knee-jerk selling. That volatility is a buying opportunity if you stick to an…
Nvidia remains the primary beneficiary of the generational AI compute cycle. Near-term headlines about an 'AI slowdown' are creating tactical buying opportunities. This trade idea outlines a disciplined long with explicit entry at $850.00, a stop at $700.00, and a target at $1100.00 over a 180-trading-day horizon.
Rubrik is benefiting from an AI-driven surge in enterprise security spending. Recent beats and a profitable quarter cooled off with post-earnings profit-taking, creating a cleaner entry for a tactical long. Valuation is rich but cash flow and growth offer room for upside; risk management is essential.
Advanced Micro Devices (AMD) has been tarred with the same brush as other AI-exposed semiconductors during a recent sector-wide selloff, but the company's fundamentals and technical read suggest a tactical long. With a market cap near $822B, strong free cash flow, low leverage, and bullish momentum indicators, AMD looks positioned to recover if AI …
Wheaton Precious Metals (WPM) is a best-in-class precious-metals streamer with durable production growth and low operating risk. That quality shows up in margins and predictable cash flows, but the stock trades at a steep premium - roughly $67.7B market cap, ~33x trailing P/E and ~7x book - leaving limited room for error. This trade idea proposes a…
Meta is trading at roughly $671 with a $1.71T market cap, strong free cash flow and accelerating AI product monetization. This trade idea lays out an actionable long with entry, stop and $1,000 target, plus catalysts and balanced risks.
Coherent (COHR) just pulled back after an earnings-fueled run. Fundamentals remain intact — revenue growth north of 30% YoY, Q1 guidance implying ~45% growth, and a multimillion-dollar hyperscaler backdrop — while technically the stock sits below short-term moving averages. This trade is a mid-term, tactical long to ride continued AI optics adoptio…
Lakefront Biotherapeutics trades below book with a market cap of roughly $1.78B while carrying a deeper pipeline and recent FDA orphan designation for gamgertamig. Technicals show near-term weakness, but the combination of shareholder accumulation and regulatory catalysts supports a mid-term long trade with tight risk controls.
